Clinical trial
Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease
NCT00095472 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00095472 |
|---|---|
| Title | Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease |
| Official title | Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sickle Cell Anemia |
| Intervention type | Drug |
| Interventions | L-NMMA, Sodium Nitrite |
| Enrollment | 18 |
| Start date | Nov 1, 2004 |
| Primary completion | Aug 24, 2007 |
| Completion | Aug 24, 2007 |
| First posted | Nov 5, 2004 |
| Last update posted | Nov 5, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: